Related Experiment Video
Updated: Jul 4, 2025
05:46
A Versatile Kit Based on Digital Microfluidics Droplet Actuation for Science Education
Published on: April 26, 2021
4.7K
An Integrative Review of Micro-Credentials and Digital Badges for Pharmacy Educators
Sarah E Vordenberg1, Nicholas M Fusco2, Kristina E Ward3
1University of Michigan, College of Pharmacy, Ann Arbor, MI, USA.
American Journal of Pharmaceutical Education
|January 25, 2024
Summary
Micro-credentials and digital badges offer flexible learning in health professions. However, barriers hinder their adoption in pharmacy education, requiring further research for effective implementation.
Area of Science:
- Health Professions Education
- Digital Learning Technologies
- Pharmacy Education
Background:
- Micro-credentials (MCs) and digital badges (DBs) are increasingly used to supplement traditional education.
- These digital tools support student-centered learning through personalized pathways and skill development.
- Existing barriers may impede the widespread adoption of MCs and DBs in health professions education.
Purpose of the Study:
- To review the literature on MCs and DBs in health professions education.
- To explore the benefits, challenges, and future applications of MCs and DBs in Doctor of Pharmacy programs.
- To address the scarcity of research on MCs and DBs within pharmacy curricula.
Main Methods:
- Integrative literature review of MCs and DBs in health professions education.
- Analysis of current research and identification of implementation barriers.
- Synthesis of perspectives on potential uses in Doctor of Pharmacy programs.
Main Results:
- MCs and DBs offer personalized, flexible, and skill-focused learning opportunities.
- Significant barriers exist for their integration into health professions education.
- Research specifically on their use in Doctor of Pharmacy programs is limited.
Conclusions:
- MCs and DBs hold promise for enhancing pharmacy education by providing flexible learning pathways.
- Addressing identified barriers is crucial for successful implementation in Doctor of Pharmacy programs.
- Further research is needed to fully understand and leverage MCs and DBs in pharmacy education.
Related Concept Videos
01:28Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
01:21Pharmacodynamics: Overview and Principles
1.1K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.1K
01:26Drug Administration and Therapy Phases: Overview
468
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
468
01:20Desensitization and Tachyphylaxis
1.7K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.7K
01:20Nursing Process for Patient and Caregiver Teaching III: Evaluation and Documentation
1.7K
Evaluation of the teaching process enables the nurse to determine if the patient's learning needs were met and if training was effective. If the expected outcomes are not met, the care plan is revised, and additional education or reinforcement is provided. Nurses can ask questions after the session or obtain feedback to assess the patient's understanding of the topic.
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
Nurses can use several methods to evaluate patient outcomes. For example, oral questions can assess cognitive learning,...
1.7K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
160
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
160